Figure 4.
Figure 4. LAT and NTAL are expressed in mouse NK cells but are dispensable for splenic NK cell maturation. (A) Lat and Ntal expression levels are expressed as relative units of indicated mRNA normalized using HPRT transcripts. Samples included purified CD4+ T cells (T), sorted (CD3–CD4–CD8–DX5+) NK cells isolated from unstimulated (NK resting) and polyIC stimulated (NK polyIC) mice, sorted (CD3–NK1.1+) LAK, enriched B220+ B cells (B), all derived from C57BL/6 mice, or total splenocytes isolated from double LAT/NTALKO mice. Data (mean ± SD) are representative of 3 independent experiments. (B) LAT and NTAL expression was analyzed on C57BL/6 (CTR) and LAT/NTALKO spleen lymphocytes by intracellular staining gating on T cells (CD3+NK1.1–), NK cells (CD3–NK1.1+), and B cells (CD3–NK1.1–). Staining performed with isotype control mAb (dotted line) has been overlaid to staining obtained using specific anti-LAT or anti-NTAL mAb (bold line). Data shown are representative of 3 independent experiments. (C) LAT and NTAL expression was analyzed by immunoblotting on lysates prepared from (1) 5 × 106 total C57BL/6 splenocytes, (2) 5 × 106 total splenocytes derived from LATKO mice, (3) 5 × 106 total splenocytes derived from NTALKO mice, (4) wild-type thymocytes (1 × 106), (5) purified (CD3–CD4–CD8–DX5+) NK cells (1 × 106), and (6) enriched (B220+) B cells (1 × 106). (D) The numbers of splenic NK cells isolated from indicated mice are represented. Dots indicate individual mice. Horizontal bars indicate mean values. Statistical analysis was performed using unpaired Student t test. (E) The cell-surface expression of indicated NK cell markers was analyzed on CD3–MHC class II–DX5+ splenocytes isolated from represented mice. Indicated mice also express comparable levels of Ly49A marker (data not shown). Data are representative of 4 independent experiments.

LAT and NTAL are expressed in mouse NK cells but are dispensable for splenic NK cell maturation. (A) Lat and Ntal expression levels are expressed as relative units of indicated mRNA normalized using HPRT transcripts. Samples included purified CD4+ T cells (T), sorted (CD3CD4CD8DX5+) NK cells isolated from unstimulated (NK resting) and polyIC stimulated (NK polyIC) mice, sorted (CD3NK1.1+) LAK, enriched B220+ B cells (B), all derived from C57BL/6 mice, or total splenocytes isolated from double LAT/NTALKO mice. Data (mean ± SD) are representative of 3 independent experiments. (B) LAT and NTAL expression was analyzed on C57BL/6 (CTR) and LAT/NTALKO spleen lymphocytes by intracellular staining gating on T cells (CD3+NK1.1), NK cells (CD3NK1.1+), and B cells (CD3NK1.1). Staining performed with isotype control mAb (dotted line) has been overlaid to staining obtained using specific anti-LAT or anti-NTAL mAb (bold line). Data shown are representative of 3 independent experiments. (C) LAT and NTAL expression was analyzed by immunoblotting on lysates prepared from (1) 5 × 106 total C57BL/6 splenocytes, (2) 5 × 106 total splenocytes derived from LATKO mice, (3) 5 × 106 total splenocytes derived from NTALKO mice, (4) wild-type thymocytes (1 × 106), (5) purified (CD3CD4CD8DX5+) NK cells (1 × 106), and (6) enriched (B220+) B cells (1 × 106). (D) The numbers of splenic NK cells isolated from indicated mice are represented. Dots indicate individual mice. Horizontal bars indicate mean values. Statistical analysis was performed using unpaired Student t test. (E) The cell-surface expression of indicated NK cell markers was analyzed on CD3MHC class IIDX5+ splenocytes isolated from represented mice. Indicated mice also express comparable levels of Ly49A marker (data not shown). Data are representative of 4 independent experiments.

Close Modal

or Create an Account

Close Modal
Close Modal